Clinical Trials Logo

Filter by:
NCT ID: NCT01412957 Active, not recruiting - Clinical trials for Metastatic Colorectal Cancer

Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal Cancer

Start date: November 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the benefit of panitumumab in addition to best supportive care compared to best supportive care alone in patients with chemorefractory wild-type KRAS (Kirsten rat sarcoma viral oncogene homolog) metastatic colorectal cancer.

NCT ID: NCT01305109 Active, not recruiting - Clinical trials for Viral Gastroenteritis Due to Rotavirus

A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E

ROTAVAC
Start date: March 2011
Phase: Phase 3
Study type: Interventional

The trial is a phase III randomized, double-blind, placebo-controlled trial with the primary objective of evaluating the efficacy of three doses of ORV 116E, 10^5.0 FFU, against severe rotavirus gastroenteritis, in comparison with a placebo in India.

NCT ID: NCT01298323 Active, not recruiting - Clinical trials for Medullary Thyroid Cancer

Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

88
Start date: February 25, 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effect of patient outreach program on the proportion of time patients with MTC experience moderate or severe AEs during first 12 months of treatment with vandetanib

NCT ID: NCT01275768 Active, not recruiting - Clinical trials for Disorder of Bile Duct Stent

Role of Endoscopic RFA in Prolonging the Patency of Metal Stents in Patients With Malignant Obstructive Jaundice

Start date: January 2011
Phase: Phase 1/Phase 2
Study type: Interventional

Patients with malignant obstructive jaundice (cancer of head of pancreas and cholangiocarcinoma) generally have a very poor prognosis with less than 20% patients having resectable disease at presentation. These patients also have a very poor quality of life with a life expectancy of 6-8 months. Jaundice associated with pruritus, poor appetite, malabsorption and loss of weight and cholangitis is the most common and troublesome problem. Placement of metallic stents has been the standard of care for patients with unresectable disease. However, about 50% of these stents get blocked in 6-8 months. Use of endoscopic Radio-frequency Ablation (RFA) prior to placement of metal stents may increase the patency of these stents

NCT ID: NCT01255995 Active, not recruiting - Clinical trials for Pseudo Exfoliation Syndrome

Natural History of IOL in Pseudo Exfoliation Syndrome

PXF
Start date: December 2010
Phase: N/A
Study type: Observational

- The purpose of this study is to determine the natural course of IOL in PXF, - To demonstrate use of a clinical grading system for PXF, - To strategize a way to prevent IOL dislocation, subluxation post operatively, - To demonstrate intraoperative and long-term post-operative complications associated with phaco and PXF - To suggest evidence-based ways to minimize these complications, by using capsular tension rings (CTR), specific IOL material or size

NCT ID: NCT01222117 Active, not recruiting - Clinical trials for Acute Peripheral Arterial Occlusion

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Start date: December 2010
Phase: Phase 2
Study type: Interventional

The primary purpose of this Phase 2 study is to optimize Plasmin delivery by comparing different delivery regimens in patients with peripheral arterial occlusion. The study includes a blinded plasminogen activator treatment group and a blinded plasminogen activator placebo group. The study will also assess safety and tolerability of Plasmin at 150 and 250 mg doses.

NCT ID: NCT01220830 Active, not recruiting - Multiple Sclerosis Clinical Trials

Cytotron® Delivered Rotational Field Quantum Nuclear Magnetic Resonance Therapy for Multiple Sclerosis

RFQMR
Start date: September 2010
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the efficacy of RFQMR therapy in remyelination in cases of Multiple sclerosis. The evaluation will be done based on MRI findings, by clinical/ neurological examination and by assessment of quality of life before and after completion of therapy.

NCT ID: NCT01152411 Active, not recruiting - Clinical trials for Chronic Renal Failure

Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Chronic Renal Failure

Start date: February 2010
Phase: Phase 1/Phase 2
Study type: Interventional

Chronic renal failure (CRF, or "chronic kidney failure", CKF, or "chronic kidney disease", CKD) is a slowly progressive loss of renal function over a period of months or years and defined as an abnormally low glomerular filtration rate, which is usually determined indirectly by the creatinine level in blood serum. CRF that leads to severe illness and requires some form of renal replacement therapy(such as dialysis) is called end-stage renal disease (ESRD). While renal replacement therapies can maintain patients indefinitely and prolong life, the quality of life is severely affected. Renal transplantation increases the survival of patients with stage 5 CKD significantly when compared to other therapeutic options; however, it is associated with an increased short-term mortality (due to complications of the surgery). In view of the above, there is definitely an urgent need for finding different methods of treatment for these patients who cannot undergo established modalities of treatment or these have been tried unsuccessfully hence the inadequacy of current treatment modalities and insufficiency of donor organs for transplantation have driven a search for improved methods of dealing with renal failure. The rising concept of cell-based therapeutics has provided a framework around which new approaches are being generated, and its combination with advances in stem cell research stands to bring both fields to clinical fruition. Since CRF affects a large number of these patients who will lose their productive life, stem cell implantation can offer some promise of improved health. In our present study, we want to evaluate the safety and efficacy (to know / observe for Proof of concept in five indian patients) if any, of autologous bone marrow derived stem cells injected into the Renal Artery in five (initially five patients, can be increased to ten patients after observing the initial results) patients with Chronic Renal Failure.

NCT ID: NCT01138176 Active, not recruiting - Clinical trials for Hypoxic Ischemic Encephalopathy

Whole Body Cooling Using Phase Changing Material

Start date: July 2009
Phase: Phase 1/Phase 2
Study type: Interventional

A prospective randomized control trial to examine safety and effectiveness of whole body cooling to a rectal temperature of 33.5 C using phase changing material in neonatal encephalopathy. Effectiveness will be defined by examining the stability of rectal temperature during cooling. Monitoring of vital signs, infection screen, blood counts, coagulation screen, liver and renal function tests, cranial US and MR imaging will be performed on recruited infants to evaluate safety of cooling. EEG will be performed on day 4 and hearing evaluation at discharge. Neurodevelopmental evaluation will be performed at 1 year of age.

NCT ID: NCT01124409 Active, not recruiting - Clinical trials for HEAD AND NECK CANCER

Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.

Start date: December 2009
Phase: Phase 3
Study type: Interventional

This study aims to study the impact image guided radiotherapy with Cone beam CT will have on the outcomes(toxicities and response) of head and neck cancer when compared to 3D conformal radiotherapy without CBCT based setup error verification.Also,the various dosimetric variations in Adaptive RT will be studied.